The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Prostate Cancer and Prostatic Diseases, Published online: 31 May 2022; doi:10.1038/s41391-022-00548-zThe EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

https://www.nature.com/articles/s41391-022-00548-z

Source: Prostate Cancer and Prostatic Diseases - May 31, 2022 Category: Urology & Nephrology Authors: Henry H. Woo Chi-Ping Huang William J. Huang Yi-Huei Chang Chi-Shun Lien Archil Chkhotua Dean S. Elterman Source Type: research

More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology